Toronto Star

Is CBD safe?

As it develops regulation, U.S. FDA remains cautious of cannabis compound ,

- KRISTINE OWRAM

CBD wholesaler­s should “have big concerns” about the U.S. Food and Drug Administra­tion’s growing unease about the safety of the cannabis compound, according to one chief executive officer.

The FDA said Monday that it “cannot conclude that CBD is generally recognized as safe among qualified experts for its use in human or animal food.”

It added that “some of the available data raise serious concerns about potential harm from CBD,” including liver injury, drowsiness, diarrhea and changes in mood, and raised questions about its impact on children and pregnant or breastfeed­ing women.

This could cause big retailers to shy away from products containing cannabidio­l, a non-intoxicati­ng compound found in the cannabis plant, said Peter Horvath, CEO of Green Growth Brands Inc.

“It could be that this FDA thing causes the chains to either cut back or discontinu­e their CBD businesses,” Horvath said in a phone interview Tuesday. “I think if you’re in a strictly wholesale strategy and if you sell ingestible­s, you’d have to have big concerns.”

Green Growth Brands primarily sells CBD topicals like lotions at mall kiosks. It also has a small ingestible­s business.

Consumer CBD stocks fell on the news, with CV Sciences Inc. down as much as 13 per cent. Charlotte’s Web Holdings Inc. lost 6.6 per cent and cbdMD Inc. slid 11 per cent.

The FDA’s statement “used an inappropri­ately alarmist tone,” Duffy MacKay, CV Sciences’ senior vice-president of scientific and regulatory affairs, said in an emailed statement. “There are more direct ways for the FDA to address bad actors while still working with responsibl­e companies to establish the appropriat­e scope of hemp-derived ingredient­s for supplement­s based on sound research.”

Bullish forecasts on CBD’s sales potential are likely to be slashed in the wake of the FDA’s “very cautious tone,” according to Jefferies analyst Owen Bennett, whose own model calls for retail sales of just $3.5 billion (U.S.) in 2022.

 ?? RICHARD B. LEVINE TRIBUNE NEWS SERVICE FILE PHOTO ?? The U.S. Food and Drug Administra­tion is concerned about CBD’s potential health effects, including on pregnant women and kids.
RICHARD B. LEVINE TRIBUNE NEWS SERVICE FILE PHOTO The U.S. Food and Drug Administra­tion is concerned about CBD’s potential health effects, including on pregnant women and kids.

Newspapers in English

Newspapers from Canada